Search

Your search keyword '"Antiviral agents -- Testing"' showing total 43 results
Start Over Descriptor "Antiviral agents -- Testing" Topic pharmaceuticals and cosmetics industries
43 results on '"Antiviral agents -- Testing"'

1. A Testament to Testing

Author

Hennessy, Mike, Jr.

Subjects
Epidemics -- Care and treatment -- Control -- United States, Antiviral agents -- Testing, Business, Pharmaceuticals and cosmetics industries
Abstract

Like oncoming hurricanes, we respond with trepidation to Greek letters for emerging COVID-19 variants. Apart from fraternities, or perhaps high-tech product names, we mostly ignore the ancient Greek alphabet. But [...]

Published
2021

2. AntiFlu therapeutic being tested

Subjects
Antiviral agents -- Testing, Pharmaceutical industry -- Product development, Biotechnology industry, Business, Pharmaceuticals and cosmetics industries
Abstract

In anticipation of an avian flu pandemic looming in the future, FLAVORx, Inc. is testing formulations of flavored anti retroviral (ARV) drugs in Thailand to increase usage of the therapeutic [...]

Published
2005

3. Hepatitis C virus (HCV) infection

Author

Kaufman, Michele B.

Subjects
Antiviral agents -- Testing, Hepatitis C -- Drug therapy, Pharmaceutical industry -- Product development, Pharmaceuticals and cosmetics industries
Abstract

Hepatitis C virus (HCV) infection Product type/proposed FDA status/ New drugs indication notes asunaprevir/ a twice-daily, oral, NS5A phase 3 BMS-650032 inhibitor/for combination Bristol-Myers Squibb treatment with daclatasvir/BMS-790052 intended for [...]

Published
2012

4. Results need reevaluation. (Off Their Tracks)

Author

Faunt, Demian

Subjects
Eli Lilly and Co. -- Product development, 3M Co. -- Product development, Pharmaceutical industry -- Product development, Antiviral agents -- Testing, Business, Pharmaceuticals and cosmetics industries
Abstract

Eli Lilly and Co. and 3M have suspended clinical trials of resiquimod, an immune response modifier compound for the treatment of genital herpes. Preliminary data from completed Phase III clinical [...]

Published
2003

5. Lamivudine's promise in hepatitis

Subjects
Shire BioChem Inc. -- Product development, Glaxo Wellcome PLC -- Product development, Pharmaceutical industry -- Product development, Antiviral agents -- Testing, Hepatitis B -- Drug therapy, Business, Pharmaceuticals and cosmetics industries, Lamivudine (Medication) -- Testing
Published
1996

6. Lidakol setback in oral herpes

Subjects
Lidak Pharmaceuticals Inc. -- Product development -- 00225955, Pharmaceutical industry -- Product development, Herpes simplex -- Drug therapy, Antiviral agents -- Testing, Business, Pharmaceuticals and cosmetics industries
Published
1996

7. Gilead broad-spec antiviral in clinic

Subjects
Gilead Sciences Inc. -- Product development -- 00223651, Antiviral agents -- Testing, Pharmaceutical industry -- Testing, Herpesviruses -- Development and progression, Prodrugs -- Testing, Business, Pharmaceuticals and cosmetics industries
Published
1996

8. Japan CT's for JT/Agouron HIV drug

Subjects
Japan Tobacco Inc. -- Product development -- 00161442, Agouron Pharmaceuticals Inc. -- Product development -- 00211436, Antiviral agents -- Testing, Pharmaceutical industry -- Testing, Business, Pharmaceuticals and cosmetics industries
Published
1996

9. AnorMED's AMD070 to progress to Ph II

Subjects
International Conference on AIDS, Pharmaceutical industry -- Planning, Pharmaceutical industry -- Product development, Antiviral agents -- Product development, Antiviral agents -- Testing, Anti-HIV agents -- Product development, Anti-HIV agents -- Testing, Company business planning, Pharmaceuticals and cosmetics industries
Abstract

At the International AIDS Conference in Bangkok, Thailand, positive Phase Ia findings were presented for AnorMED's potential anti-HIV therapy AMD070. The study, involving 30 healthy volunteers, revealed that oral administration [...]

Published
2004

10. Panacos Pharmaceuticals has begun a Phase I clinical trial

Subjects
Panacos Pharmaceuticals Inc. -- Research, Pharmaceutical industry -- Research, Antiviral agents -- Testing, Anti-HIV agents -- Testing, Clinical trials, Health care industry, Pharmaceuticals and cosmetics industries
Abstract

* Panacos Pharmaceuticals has begun a Phase I clinical trial of its small molecule HIV drug candidate [...]

Published
2004

11. ViroPharma/Wyeth's HCV-086 enters clinic

Subjects
ViroPharma Inc. -- Product development, Wyeth -- Product development, Pharmaceutical industry -- Product development, Hepatitis C -- Care and treatment, Antiviral agents -- Testing, Pharmaceuticals and cosmetics industries
Abstract

US firms ViroPharma and Wyeth have initiated a Phase I clinical program for HCV-086, an antiviral agent with potential use in the treatment of hepatitis C. The companies will initially [...]

Published
2004

12. Shaman delays Provir trial

Subjects
Shaman Pharmaceuticals Inc. -- Research -- 00239007, Pharmaceutical industry -- Research, Antiviral agents -- Testing, Business, Pharmaceuticals and cosmetics industries
Published
1995

13. Scotia's EF13 in Phase II for AIDS

Subjects
Scotia Pharmaceuticals Ltd. -- Product development, Antiviral agents -- Testing, Pharmaceutical industry -- Product development, AIDS (Disease) -- Drug therapy, Business, Pharmaceuticals and cosmetics industries
Published
1994

14. 3TC/zidovudine's high potency in HIV

Subjects
Shire BioChem Inc. -- Product development, Wellcome PLC -- Product development, Glaxo Inc. -- Product development, Antiviral agents -- Testing, Zidovudine -- Testing, HIV infection -- Drug therapy, Business, Pharmaceuticals and cosmetics industries
Published
1994

15. CPMP positive on Roferon for hep C

Subjects
Roche Holding Ltd. -- Product information, Hepatitis C -- Drug therapy, Antiviral agents -- Testing, Business, Pharmaceuticals and cosmetics industries, European Union. Committee for Proprietary Medicinal Products -- Laws, regulations and rules -- Usage, Roferon-A (Medication)
Published
1994

17. Gilead's GS-840 enters Phase I/II for AIDS

Subjects
Gilead Sciences Inc. -- Product development, Prodrugs -- Testing, HIV infection -- Drug therapy, Antiviral agents -- Testing, Pharmaceutical industry -- Product development, Business, Pharmaceuticals and cosmetics industries
Published
1994

18. Lamivudine enters Phase III

Subjects
Glaxo Inc. -- Product development, Hepatitis B -- Drug therapy, Antiviral agents -- Testing, Pharmaceutical industry -- Product development, Business, Pharmaceuticals and cosmetics industries
Published
1994

19. Sorivudine continuing in US

Subjects
Nippon Shoji -- Product development, Yamasa Shoyu Company Ltd. -- Product development, Bristol-Myers Squibb Co. -- Licensing agreements, Antiviral agents -- Testing, Varicella-zoster virus -- Drug therapy, Business, Pharmaceuticals and cosmetics industries
Published
1994

20. Famciclovir's edge over aciclovir?

Subjects
Herpesvirus diseases -- Research, Antiviral agents -- Testing, Business, Pharmaceuticals and cosmetics industries
Published
1994

21. Phase III study with Lidakol in oral herpes

Subjects
Yamanouchi Europe -- Research, Pharmaceutical industry -- Research, Antiviral agents -- Testing, Business, Pharmaceuticals and cosmetics industries
Published
1994

22. Antiviral effects of Repligen's AM285

Subjects
Repligen Corp. -- Product development, Antiviral agents -- Testing, Pharmaceutical industry -- Product development, Creatine kinase -- Research, Business, Pharmaceuticals and cosmetics industries
Published
1994

23. Lidak Pharmaceuticals' Lidakol in genital herpes

Subjects
Lidak Pharmaceuticals Inc. -- Product development, Antiviral agents -- Testing, Herpes genitalis -- Complications, Pain -- Care and treatment, Pharmaceutical industry -- Product development, Business, Pharmaceuticals and cosmetics industries, Lidakol (Medication) -- Testing
Published
1994

24. Sparta developing anticancers/antivirals

Subjects
Sparta Pharmaceuticals -- Product development, Pharmaceutical industry -- Product development, Antineoplastic agents -- Testing, Antiviral agents -- Testing, Business, Pharmaceuticals and cosmetics industries
Published
1994

25. Shaman's Phase II antiherpes trials

Subjects
Shaman Pharmaceuticals Inc. -- Product development, Herpes -- Drug therapy, Antiviral agents -- Testing, Pharmaceutical industry -- Product development, Business, Pharmaceuticals and cosmetics industries, Virend (Medication) -- Testing
Published
1994

26. Gilead's AIDS research progress

Subjects
Gilead Sciences Inc. -- Product development, AIDS (Disease) -- Drug therapy, Pharmaceutical industry -- Product development, Antiviral agents -- Testing, Business, Pharmaceuticals and cosmetics industries
Published
1994

27. Medivir reports positive results for MIV-210

Subjects
Medivir AB -- Product information, Pharmaceutical industry -- Testing, Antiviral agents -- Testing, Business, Business, international, Pharmaceuticals and cosmetics industries
Abstract

M2 EUROPHARMA-(C)1999-2002 M2 COMMUNICATIONS LTD Swedish pharmaceutical research and development firm Medivir AB has revealed positive preclinical results for its HIV and hepatitis B antiviral MIV-210. The preclinical studies aimed [...]

Published
2002

28. NIH to sponsor HIV trials with VIMRx' oral hypericin

Subjects
United States. National Institutes of Health -- Finance, VIMRx Pharmaceuticals Inc. -- Product development, Antiviral agents -- Testing, Hypericin -- Dosage and administration, HIV infection -- Drug therapy, Business, Pharmaceuticals and cosmetics industries
Published
1993

29. Shaman's human safety studies with Provir

Subjects
Shaman Pharmaceuticals Inc. -- Product development, Antiviral agents -- Testing, Respiratory syncytial virus -- Research, Pharmaceutical industry -- Product development, Business, Pharmaceuticals and cosmetics industries
Published
1993

30. Lamivudine for hepatitis

Subjects
Shire BioChem Inc. -- Product development, Glaxo Inc. -- Product development, Antiviral agents -- Testing, Hepatitis B -- Drug therapy, Pharmaceutical industry -- Product development, Business, Pharmaceuticals and cosmetics industries
Published
1993

31. Advanced Magnetics tests antiviral

Subjects
Advanced Magnetics Inc. -- Product development, Antiviral agents -- Testing, Hepatitis -- Drug therapy, Chemotherapy -- Adverse and side effects, Biological products industry -- Product development, Business, Pharmaceuticals and cosmetics industries
Published
1993

32. Somatogen's support of AIDS clinical trials network

Subjects
Somatogen Inc. -- Finance, Antiviral agents -- Testing, AIDS (Disease) -- Drug therapy, Biological products industry -- Finance, Business, Pharmaceuticals and cosmetics industries, American Foundation for AIDS Research -- Finance
Published
1993

33. Immunotherapy Added to First Cycle of Antiviral Cocktails

Subjects
HemispheRx BioPharma Inc. -- Product development, Antiviral agents -- Testing, Anti-HIV agents -- Testing, Pharmaceutical industry -- Product development, Pharmaceuticals and cosmetics industries, Ampligen (Medication) -- Evaluation -- Product/service Evaluations
Abstract

2001 JAN 26 - (NewsRx.com) -- Hemispherx Biopharma, Inc., announced January 3, 2001, a newly reviewed U.S. Food and Drug Administration (FDA) clinical protocol designed to test the blunting of [...]

Published
2001

34. Lamivudine enters trials for hepatitis

Subjects
Shire BioChem Inc. -- Research, Glaxo Pharmaceuticals Inc. -- Research, Antiviral agents -- Testing, Pharmaceutical industry -- Research, Drugs -- Testing, Hepatitis -- Prevention, Business, Pharmaceuticals and cosmetics industries
Published
1992

35. VIMRx begins trials in human papillomavirus infection

Subjects
VIMRx Pharmaceuticals Inc. -- Contracts, Pharmaceutical industry -- Contracts, Hospitals -- Contracts, Antiviral agents -- Testing, Papillomaviruses -- Care and treatment, Business, Pharmaceuticals and cosmetics industries, Beth Israel Hospital -- Contracts, VIMRxyn (Medication) -- Testing
Published
1992

36. Tamoxifen - an antiviral?

Subjects
Pharmaceutical industry -- Research, Tamoxifen -- Research, Antiviral agents -- Testing, Business, Pharmaceuticals and cosmetics industries
Published
1992

38. Lidakol - a broad-spectrum antiviral?

Subjects
Lidak Pharmaceuticals Inc. -- Research, Proceedings of the National Academy of Science (Periodical) -- Reports, Antiviral agents -- Testing, Pharmaceutical industry -- Research, Virus diseases -- Drug therapy, Business, Pharmaceuticals and cosmetics industries, Lidakol (Medication) -- Testing
Published
1991

39. Shaman Pharmaceuticals' CTs with antiviral agent

Subjects
Shaman Pharmaceuticals Inc. -- Research, Pharmaceutical industry -- Research, Antiviral agents -- Testing, Chemical tests and reagents -- Research, Business, Pharmaceuticals and cosmetics industries
Published
1991

40. Drug test pact

Subjects
United States. National Cancer Institute -- Contracts, Roberts Pharmaceutical Corp. -- Contracts, Antineoplastic agents -- Testing, Antiviral agents -- Testing, Business, Pharmaceuticals and cosmetics industries, Retail industry
Abstract

Drug Test Pact EATONTOWN, N.J. - The National Cancer Institute has agreed to test Roberts Pharmaceutical Corp.'s drugs for their efficacy in the treatment of cancer and AIDS. 'The institute [...]

Published
1991

41. Surrogate markers in AIDS trials

Subjects
Antiviral agents -- Testing, Cell surface antigens -- Research, AIDS (Disease) -- Research, Business, Pharmaceuticals and cosmetics industries
Published
1991

42. DDI promising in children

Subjects
Bristol-Myers Squibb Co. -- Research, Antiviral agents -- Testing, AIDS (Disease) in children -- Drug therapy, Didanosine -- Testing, Business, Pharmaceuticals and cosmetics industries
Published
1991

43. Elan's antibiotic & AIDS products

Subjects
Elan Pharmaceutical Research Corp. -- Research, Drug resistance in microorganisms -- Research, Antiviral agents -- Testing, Business, Pharmaceuticals and cosmetics industries
Published
1991

Catalog

Books, media, physical & digital resources
See catalog results